Xeraya Capital — Full Portfolio
35 tracked investments · listed companies and verified rows first
Foghorn Therapeutics is a clinical-stage biotech developing chromatin-targeted cancer drugs via its Gene Traffic Control platform, including a candidate co-developed with Eli Lilly.
Adrian Gottschalk(President and Chief Executive Officer)
Co-investorsFlagship PioneeringBiotechnology Value FundDeerfield Management Company
Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
BiotechMorrisville, US
Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in
BoardPaul B. Manning(Director)inStephen Bloch(Director)inJoanna Horobin(Director)Raman Singh(Director)
Co-investorsCanaan PartnersNew Enterprise Associates (NEA)PBM Capital
Rapid Micro Biosystems manufactures automated laboratory testing systems and consumables for pharmaceutical and cell therapy manufacturers to conduct microbiological quality control testing, replacing manual methods with platform-based analysis.
HealthtechLowell, US
Robert Spignesi(Executive Officer, Director)inStephen H. Delity(Executive Officer, Director)Michael J. Mullen(Executive Officer)
BoardDavid Hirsch(Director)Richard S. Kollender(Director)Fred Cohen(Director)
Co-investorsEndeavour VisionKleiner PerkinsLongitude CapitalAlly Bridge Group
P2 Science develops green chemistry platform technologies (including its PIOz ozonolysis and PICE polymerization processes) that convert renewable, plant-based oils into functional intermediates, specialty ingredients, and polymers.
BiotechCircular EconomyCleantechNew MaterialsWoodbridge, US
Paul Anastas(Co-founder)Patrick Foley(Co-founder & President)inNeil A. Burns(Executive Officer, Director)Oihana Elizalde(Chief Executive Officer)inBrian Chan(Chief Financial Officer)inKevin Gallagher(Director)
Co-investorsCircular Innovation FundConnecticut InnovationsElm Street VenturesEmerald Technology Ventures AgHG VenturesSafer Made+2 more
HealthtechCarlsbad, US
Christoph Scharf(Director)inRandy Werneth(Executive Officer, Director)Graydon Beatty(Executive Officer)inVince Burgess(Director)inJohn Dahldorf(Executive Officer)
BoardAditya Puri(Director)
Co-investorsAdvent Life SciencesOrbiMedDeerfield Management CompanyFormation GroupGE VenturesIndex Ventures
Agerpoint provides an AI-powered field intelligence platform that combines smartphone scans, LiDAR, satellite imagery, drones, sensors, and connected equipment data to analyze crops, trees, and field conditions in production agriculture.
AgTechAI & Machine LearningClimate TechOrlando, US
K. Thomas McPeek(Executive Officer, Director, Promoter)inKevin Lang(CEO & President)inMichael Gomes(VP & GM, Intelligent Equipment)inGary Rudolph(VP, Engineering)inMike Batesole(CFO)in
Co-investorsBlackhorn VenturesSpruce Capital PartnersCultivation Capital
All G produces high-value proteins using precision fermentation technology for infant formula, dietary supplements, and personal care applications.
AgTechBiotechDeep TechFoodTechSydney, AU
Jan Pacas(CEO)inJared Raynes(Chief Scientific Officer)in
Co-investorsAgronomicsVirescent VenturesDoehler VenturesEllerston Capital
Antibiotic developer, maker of cefepime/enmetazobactam (EXBLIFEP).
Co-investorsAndera PartnersBioMedPartnersDelos CapitalEMBL VenturesForbion
BiotechHealthtechSt. Paul, US
Joshua Woolley(Executive Officer)inRyan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)inPeter DeLange(Executive Officer)inBruce A. Machmeier(Executive Officer)
Co-investorsAngel Physicians FundBrightstone Venture CapitalBroadview VenturesCatalyst Health VenturesPortfoliaBioStar Ventures
Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Co-investorsCambridge Innovation CapitalFuture Planet CapitalQVenturesAmadeus Capital PartnersIDO InvestmentsLegal & General+3 more
Consumer Physics (SCiO) makes a handheld near-infrared spectroscopy scanner paired with a database of molecular signatures to analyze the chemical composition of physical materials.
AgTechAI & Machine LearningDeep TechFoodTechHardwareHerzliya
Damian Goldring(Executive Officer)inDror Sharon(Executive Officer, Director)inHaiyin Shen(Director)William Rosenzweig(Director)
BoardBenny Buller(Director)
Co-investorsSpruce Capital PartnersKhosla VenturesOurCrowd
Crop Enhancement develops CropCoat, a nontoxic crop treatment that leaves no residue on the harvested crop, aimed at agricultural growers.
AgTechNew Materials
Co-investors1955 CapitalBandgap VenturesPhoenix Venture PartnersSpruce Capital Partners
GreenLight Biosciences develops RNA-based solutions for agriculture and pest control, including a Colorado potato beetle bio-insecticide and a Varroa destructor mite-control product for sustainable food production.
AgTechBiotechImpact & Social GoodMedford, US
Andrey Zarur(Executive Officer, Director)inMarta Ortega-Valle(Executive Officer)inWilliam Blake(Executive Officer)in
BoardDavid Furneaux(Director)Jonathan Fleming(Director)James Swartz(Director)
Co-investorsBaird CapitalFall Line CapitalFuture VenturesLewis & Clark VenturesPrelude VenturesS2G Investments+3 more
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsFrazier Life SciencesHighlight CapitalMRL Ventures FundAmgen VenturesBlackRockBlackstone Life Sciences+5 more
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.
BiotechDigital HealthFemTechHealthtechMedical DevicesWellness & FitnessSacramento, US
David J. Kyle(Executive Officer, Director)inJ. Bruce German(Co-founder)David Mills(Founder)inCarlito Lebrilla(Founder)Daniela Barile(Founder)Samara Freeman(Founder & Executive Director, Regulatory Affairs & Intellectual Property)in
Co-investorsAcre Venture PartnersBow CapitalHorizons VenturesiSelect FundLongitude CapitalSpruce Capital Partners+1 more
BiotechBoulder, US
Michael Graige(Executive Officer)Ron McGrath(Executive Officer)Sri Kosaraju(Executive Officer, Director)Dianna L. DeVore(Executive Officer)Kevin Ness(Founder)inRyan Gill(Founder)
Co-investorsForesite CapitaliGlobe PartnersKorysOak HC/FTOMX VenturesPaladin Capital Group+4 more
Aldo Carrascoso(Founder)Carlito Lebrilla(Founder)inCarolyn Bertozzi(Founder)
Co-investorsAmplify PartnersAnzu PartnersGenoa VenturesSoftBank Vision FundTrue Ventures
LanzaTech converts carbon-rich gases from industrial sources like steel mills and landfills into fuels and chemicals using synthetic biology.
Circular EconomyCleantechClimate Tech
Dr. Jennifer Holmgren(CEO)Richard Forster(Founder)Sean Simpson(Founder)
Co-investorsNovo HoldingsActivant CapitalKhosla VenturesOutset VenturesQiming Venture PartnersSaints Capital+2 more
Mirxes develops RNA-based molecular diagnostics for early cancer detection, treatment selection, and multiomics research.
BiotechHealthtechMedical Devices
Co-investorsEDB InvestmentsMitsui & Co
HealthtechTewksbury, US
Lisa Mastromattei(Executive Officer)Lisa Wipperman Heine(Executive Officer)Sophia Wong(Executive Officer)Richard P. Geoffrion(Executive Officer, Director)
BoardMartien Van Osch(Director)Daniel Cole(Director)
Co-investors415 CapitalQiming Venture PartnersSaints CapitalForbionOxford Bioscience Partners
BiotechPhoenix, US
Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)Jason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)
Co-investorsB Capital GroupBoehringer Ingelheim Venture FundCity Hill VenturesDelos CapitalKorea Investment PartnersLumira Ventures+1 more
Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics.
AgTechBiotechEmeryville, US
Alvin Tamsir(Founder)inKarsten Temme(Founder)inAlvin Tamsir, Ph.D.(Chief Science Officer & Co-Founder)Karsten Temme, Ph.D.(Chief Innovation Officer and Co-Founder)Chris Abbott(Chief Executive Officer)in
BoardRoger Wyse(Director)in
Co-investorsBreakthrough Energy VenturesCongruent VenturesDCVC (Data Collective)G2 Venture PartnersK3 VenturesK3V Ventures+10 more
AgTechSanta Monica, US
Frances Arnold(Director)inPeter Meinhold(Executive Officer)inPedro Coelho(Executive Officer)inCorey Huck(Executive Officer, Director)in
BoardGANESH KISHORE(Director)inALAN BOYCE(Director)
Co-investorsAliment CapitalKairos Venture Investments, LlcLanx CapitalPontifax AgTechSpruce Capital PartnersVivo Capital+1 more
Spruce Capital Partners creates, advises, and invests in life sciences companies that make positive environmental impacts and improve human health and wellness.
BiotechClimate TechHealthtech
Roger WyseGanesh KishoreGreg Young
ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment.
HardwareHealthtechMedical DevicesOakwood Village, US
James F. Dempsey(Executive Officer, Director)inDavid Chandler(Mr. Chandler is the Chief Financial Officer of the Issuer.)Chris A. Raanes(Executive Officer, Director)Michael Brandt(Executive Officer)D. David Chandler(Executive Officer)Gregory M. Ayers(President and Chief Executive Officer of the Issuer.)
Co-investorsAisling CapitalF-Prime CapitalOrbiMed
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AmforaConforMISGreenLight Pandemic ResponseIconic TherapeuticsInvendo MedicalMirxesMLS CapitalP2SBiVittamed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









































































.jpeg)




















